Sirona Biochem Corp. stock fell 18.8% to C$0.07, trading volumes up 44% from average.

Sirona Biochem Corp.'s stock dropped 18.8% to C$0.07 on Tuesday, trading 112,944 shares, a 44% increase from the average volume. The company, which develops cosmetic and pharmaceutical ingredients in Canada and France, has a market cap of C$16.69 million and projects including a skin lightener and diabetes drug. Financial metrics show a debt-to-equity ratio of 219.21 and a current ratio of 0.34.

3 months ago
17 Articles